{"id":"https://openalex.org/W7225458589","doi":"https://doi.org/10.1021/acs.jmedchem.6c01912","title":"Diverse Computational Strategies Enable the Discovery of p38\u03b1\u2212MK2 Molecular Glues","display_name":"Diverse Computational Strategies Enable the Discovery of p38\u03b1\u2212MK2 Molecular Glues","publication_year":2026,"publication_date":"2026-11-07","ids":{"openalex":"https://openalex.org/W7225458589","doi":"https://doi.org/10.1021/acs.jmedchem.6c01912"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.6c01912","doi":"https://doi.org/10.1021/acs.jmedchem.6c01912","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6c01912","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161191010","display_name":"Gang Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gang Wang","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050668827","display_name":"Zef A. K\u00f6nst","orcid":"https://orcid.org/0009-0009-5384-7137","observed_orcids":["https://orcid.org/0009-0009-5384-7137"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zef A. Ko\u0308nst","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084246316","display_name":"Markus K. Dahlgren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Markus K. Dahlgren","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161182769","display_name":"Pooja Arora","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pooja Arora","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014453262","display_name":"\u00c9ric Therrien","orcid":"https://orcid.org/0000-0003-3306-9162","observed_orcids":["https://orcid.org/0000-0003-3306-9162"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Therrien","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":"https://orcid.org/0000-0003-3306-9162","affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161189852","display_name":"Sung-Sau So","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sung-Sau So","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019888088","display_name":"Pieter H. Bos","orcid":"https://orcid.org/0000-0002-8710-4771","observed_orcids":["https://orcid.org/0000-0002-8710-4771"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pieter H. Bos","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":"https://orcid.org/0000-0002-8710-4771","affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073661430","display_name":"Jeffrey A. Bell","orcid":"https://orcid.org/0000-0002-8310-0183","observed_orcids":["https://orcid.org/0000-0002-8310-0183"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Bell","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":"https://orcid.org/0000-0002-8310-0183","affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021850958","display_name":"Michael A. DiMattia","orcid":"https://orcid.org/0009-0000-8349-3936","observed_orcids":["https://orcid.org/0009-0000-8349-3936"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. DiMattia","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076470445","display_name":"Eric A. Evangelista","orcid":"https://orcid.org/0000-0003-4975-2636","observed_orcids":["https://orcid.org/0000-0003-4975-2636"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric A. Evangelista","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":"https://orcid.org/0000-0003-4975-2636","affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102685600","display_name":"Yefen Zou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yefen Zou","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033131615","display_name":"Alan S. Futran","orcid":"https://orcid.org/0000-0002-2132-312X","observed_orcids":["https://orcid.org/0000-0002-2132-312X"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan S. Futran","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008391873","display_name":"Kun Yao","orcid":"https://orcid.org/0000-0003-2032-7441","observed_orcids":["https://orcid.org/0000-0003-2032-7441","https://orcid.org/0009-0003-4768-952X","https://orcid.org/0009-0009-5572-7761"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kun Yao","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043234999","display_name":"Nicholas A. Boyles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas A. Boyles","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018229309","display_name":"Susanta Haldar","orcid":"https://orcid.org/0000-0001-8642-109X","observed_orcids":["https://orcid.org/0000-0001-8642-109X"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanta Haldar","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110212212","display_name":"M Salmon","orcid":"https://orcid.org/0000-0002-6029-8772","observed_orcids":["https://orcid.org/0000-0002-6029-8772"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Salmon","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022991788","display_name":"Sathesh Bhat","orcid":"https://orcid.org/0000-0003-1819-5726","observed_orcids":["https://orcid.org/0000-0003-1819-5726"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sathesh Bhat","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":"https://orcid.org/0000-0003-1819-5726","affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002163642","display_name":"Aleksey I. Gerasyuto","orcid":"https://orcid.org/0009-0001-2696-7207","observed_orcids":["https://orcid.org/0009-0001-2696-7207"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aleksey I. Gerasyuto","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":"https://orcid.org/0009-0001-2696-7207","affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067915132","display_name":"Hideyuki Igawa","orcid":"https://orcid.org/0009-0007-3802-6344","observed_orcids":["https://orcid.org/0009-0007-3802-6344"]},"institutions":[{"id":"https://openalex.org/I203455613","display_name":"Schrodinger (United States)","ror":"https://ror.org/05a3z6914","country_code":"US","type":"company","lineage":["https://openalex.org/I203455613"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hideyuki Igawa","raw_affiliation_strings":["Schro\u0308dinger Inc. , , ,"],"raw_orcid":"https://orcid.org/0009-0007-3802-6344","affiliations":[{"raw_affiliation_string":"Schro\u0308dinger Inc. , , ,","institution_ids":["https://openalex.org/I203455613"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5067915132"],"corresponding_institution_ids":["https://openalex.org/I203455613"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/au-rich-element-binding-proteins","display_name":"AU-rich element-binding proteins","score":0.9440000057220459},{"id":"https://openalex.org/keywords/free-energy-perturbation","display_name":"free energy perturbation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/lps-induced-inflammation","display_name":"lipopolysaccharide-induced inflammation","score":0.8629999756813049},{"id":"https://openalex.org/keywords/kinase-inhibitor-design","display_name":"kinase inhibitor design","score":0.3449999988079071}],"concepts":[{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.8422999978065491},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7250999808311462},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.694599986076355},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5126000046730042},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.41920000314712524},{"id":"https://openalex.org/C86756495","wikidata":"https://www.wikidata.org/wiki/Q7702931","display_name":"Ternary complex","level":3,"score":0.3984000086784363},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3538999855518341},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.3352000117301941},{"id":"https://openalex.org/C69366308","wikidata":"https://www.wikidata.org/wiki/Q2272286","display_name":"ADME","level":3,"score":0.33500000834465027},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.3294000029563904},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.3215000033378601},{"id":"https://openalex.org/C63222358","wikidata":"https://www.wikidata.org/wiki/Q6120337","display_name":"chEMBL","level":3,"score":0.31690001487731934},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.30970001220703125},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3082999885082245},{"id":"https://openalex.org/C162641036","wikidata":"https://www.wikidata.org/wiki/Q5500215","display_name":"Free energy perturbation","level":3,"score":0.305400013923645},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2953000068664551},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.2939999997615814},{"id":"https://openalex.org/C2780430158","wikidata":"https://www.wikidata.org/wiki/Q7685902","display_name":"Target protein","level":3,"score":0.2849000096321106},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.28459998965263367},{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.2728999853134155},{"id":"https://openalex.org/C104292427","wikidata":"https://www.wikidata.org/wiki/Q899781","display_name":"Protein subunit","level":3,"score":0.25940001010894775},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.2590000033378601}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/acs.jmedchem.6c01912","doi":"https://doi.org/10.1021/acs.jmedchem.6c01912","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6c01912","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1555014582","https://openalex.org/W1566502635","https://openalex.org/W1780354739","https://openalex.org/W1976462601","https://openalex.org/W1989232881","https://openalex.org/W2009121644","https://openalex.org/W2053440052","https://openalex.org/W2056445309","https://openalex.org/W2059069515","https://openalex.org/W2076810768","https://openalex.org/W2081130105","https://openalex.org/W2084365684","https://openalex.org/W2126082558","https://openalex.org/W2127551467","https://openalex.org/W2154670681","https://openalex.org/W2325051172","https://openalex.org/W2342992511","https://openalex.org/W2773360516","https://openalex.org/W2789800940","https://openalex.org/W2889965257","https://openalex.org/W2967422457","https://openalex.org/W3013139410","https://openalex.org/W3037564779","https://openalex.org/W3041437958","https://openalex.org/W3151633358","https://openalex.org/W3167019654","https://openalex.org/W3170807342","https://openalex.org/W3176624364","https://openalex.org/W4225637038","https://openalex.org/W4281877807","https://openalex.org/W4292483106","https://openalex.org/W4321480727","https://openalex.org/W4376129086"],"related_works":["https://openalex.org/W2963837188","https://openalex.org/W2325051172","https://openalex.org/W2558681209","https://openalex.org/W1987886766","https://openalex.org/W2161350993","https://openalex.org/W1999804117","https://openalex.org/W2159739964","https://openalex.org/W7139945594","https://openalex.org/W4404447567","https://openalex.org/W2009501744"],"abstract_inverted_index":{"Abstract":[0],"Mitogen-activated":[1],"protein":[2,4],"kinase-activated":[3],"kinase":[5,31],"2":[6],"(MK2)":[7],"phosphorylates":[8],"AU-rich":[9],"element-binding":[10],"proteins":[11],"(AUBPs)":[12],"that":[13],"modulate":[14],"the":[15,131],"stability":[16],"of":[17,23,45,53,111,120,133,142],"cytokine":[18],"mRNA.":[19],"An":[20],"emerging":[21],"class":[22],"inhibitors":[24,44],"creates":[25],"a":[26],"ternary":[27],"complex":[28],"between":[29],"upstream":[30],"p38\u03b1":[32,47],"and":[33,79,86,92,101,116,140],"MK2.":[34],"These":[35],"molecular":[36,96,144],"glues":[37],"demonstrate":[38],"sustained":[39],"efficacy":[40],"relative":[41],"to":[42,57,77],"orthosteric":[43],"either":[46],"or":[48],"MK2;":[49],"however,":[50],"their":[51],"mechanism":[52],"action":[54],"presents":[55],"challenges":[56],"computationally":[58],"driven":[59],"design.":[60],"Herein":[61],"we":[62],"describe":[63],"in":[64,126,135],"silico":[65,136],"hit":[66,137],"identification":[67,138],"strategies":[68,139],"leveraging":[69],"free":[70],"energy":[71],"perturbation":[72],"coupled":[73],"with":[74,108],"machine":[75],"learning":[76],"triage":[78],"prioritize":[80],"ligands":[81],"from":[82],"diverse":[83],"chemical":[84],"sources":[85],"identify":[87],"multiple":[88],"structurally":[89],"diverse,":[90],"potent,":[91],"highly":[93],"selective":[94],"p38\u03b1\u2212MK2":[95],"glues.":[97,145],"Lead":[98],"compounds":[99],"14":[100],"28":[102],"demonstrated":[103],"an":[104],"attractive":[105],"PK":[106],"profile":[107],"sufficient":[109],"coverage":[110],"human":[112],"whole":[113],"blood":[114],"EC50":[115],"displayed":[117],"pronounced":[118],"reduction":[119],"TNF\u03b1":[121],"levels":[122],"after":[123],"PO":[124],"dosing":[125],"lipopolysaccharide":[127],"mouse":[128],"models,":[129],"illustrating":[130],"value":[132],"our":[134],"optimization":[141],"non-degrading":[143]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-08T00:00:00"}